Molecular Cardiotoxic Effects of Proteasome Inhibitors Carfilzomib and Ixazomib and Their Combination with Dexamethasone Involve Mitochondrial Dysregulation.

Jannuzzi A. T.Korkmaz N. S.Gunaydin Akyildiz A.Arslan Eseryel S.Karademir Yilmaz B.Alpertunga B.2023-02-242023-02-242023-02-21Jannuzzi A. T., Korkmaz N. S., Gunaydin Akyildiz A., Arslan Eseryel S., Karademir Yilmaz B., Alpertunga B., "Molecular Cardiotoxic Effects of Proteasome Inhibitors Carfilzomib and Ixazomib and Their Combination with Dexamethasone Involve Mitochondrial Dysregulation.", Cardiovascular toxicology, 20231530-7905https://hdl.handle.net/20.500.12645/37112info:eu-repo/semantics/openAccessMolecular Cardiotoxic Effects of Proteasome Inhibitors Carfilzomib and Ixazomib and Their Combination with Dexamethasone Involve Mitochondrial Dysregulation.Article10.1007/s12012-023-09785-736809482